nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Common cold—Pravastatin—atherosclerosis	0.0377	0.045	CcSEcCtD
Gallamine Triethiodide—Upset stomach—Lovastatin—atherosclerosis	0.0177	0.0212	CcSEcCtD
Gallamine Triethiodide—Upset stomach—Simvastatin—atherosclerosis	0.0166	0.0198	CcSEcCtD
Gallamine Triethiodide—Blood disorder—Rosuvastatin—atherosclerosis	0.0164	0.0196	CcSEcCtD
Gallamine Triethiodide—Hypothyroidism—Niacin—atherosclerosis	0.0156	0.0186	CcSEcCtD
Gallamine Triethiodide—Eye irritation—Lovastatin—atherosclerosis	0.0136	0.0163	CcSEcCtD
Gallamine Triethiodide—Neoplasm malignant—Ezetimibe—atherosclerosis	0.0134	0.0159	CcSEcCtD
Gallamine Triethiodide—Tenderness—Lovastatin—atherosclerosis	0.0133	0.0159	CcSEcCtD
Gallamine Triethiodide—Endocrine disorder—Simvastatin—atherosclerosis	0.0131	0.0157	CcSEcCtD
Gallamine Triethiodide—Tenderness—Simvastatin—atherosclerosis	0.0125	0.0149	CcSEcCtD
Gallamine Triethiodide—Tingling sensation—Niacin—atherosclerosis	0.0124	0.0148	CcSEcCtD
Gallamine Triethiodide—Numbness—Pravastatin—atherosclerosis	0.0119	0.0142	CcSEcCtD
Gallamine Triethiodide—Sensory loss—Pravastatin—atherosclerosis	0.0114	0.0136	CcSEcCtD
Gallamine Triethiodide—Tenderness—Pravastatin—atherosclerosis	0.0113	0.0135	CcSEcCtD
Gallamine Triethiodide—Swelling—Simvastatin—atherosclerosis	0.00895	0.0107	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Ezetimibe—atherosclerosis	0.0074	0.00884	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00725	0.00866	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Lovastatin—atherosclerosis	0.00722	0.00863	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Ezetimibe—atherosclerosis	0.00708	0.00846	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Lovastatin—atherosclerosis	0.00699	0.00835	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Rosuvastatin—atherosclerosis	0.00691	0.00825	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Simvastatin—atherosclerosis	0.00676	0.00807	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Simvastatin—atherosclerosis	0.00654	0.00781	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Pravastatin—atherosclerosis	0.00638	0.00762	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Pravastatin—atherosclerosis	0.00611	0.00729	CcSEcCtD
Gallamine Triethiodide—Angioedema—Rosuvastatin—atherosclerosis	0.00548	0.00654	CcSEcCtD
Gallamine Triethiodide—Cough—Rosuvastatin—atherosclerosis	0.00523	0.00625	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Rosuvastatin—atherosclerosis	0.00511	0.0061	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Niacin—atherosclerosis	0.00504	0.00602	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Niacin—atherosclerosis	0.00503	0.006	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Niacin—atherosclerosis	0.00502	0.00599	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Niacin—atherosclerosis	0.00499	0.00596	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Lovastatin—atherosclerosis	0.00498	0.00594	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Pravastatin—atherosclerosis	0.00495	0.00591	CcSEcCtD
Gallamine Triethiodide—Confusional state—Rosuvastatin—atherosclerosis	0.00494	0.00589	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Pravastatin—atherosclerosis	0.00491	0.00587	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00479	0.00572	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Niacin—atherosclerosis	0.00469	0.0056	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Simvastatin—atherosclerosis	0.00466	0.00556	CcSEcCtD
Gallamine Triethiodide—Angioedema—Lovastatin—atherosclerosis	0.00464	0.00555	CcSEcCtD
Gallamine Triethiodide—Anaemia—Ezetimibe—atherosclerosis	0.00461	0.0055	CcSEcCtD
Gallamine Triethiodide—Malaise—Lovastatin—atherosclerosis	0.00458	0.00547	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Pravastatin—atherosclerosis	0.00458	0.00547	CcSEcCtD
Gallamine Triethiodide—Angioedema—Ezetimibe—atherosclerosis	0.00456	0.00544	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Lovastatin—atherosclerosis	0.00455	0.00543	CcSEcCtD
Gallamine Triethiodide—Malaise—Ezetimibe—atherosclerosis	0.0045	0.00537	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00446	0.00533	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Rosuvastatin—atherosclerosis	0.0044	0.00525	CcSEcCtD
Gallamine Triethiodide—Anaemia—Simvastatin—atherosclerosis	0.00439	0.00525	CcSEcCtD
Gallamine Triethiodide—Cough—Ezetimibe—atherosclerosis	0.00435	0.0052	CcSEcCtD
Gallamine Triethiodide—Angioedema—Simvastatin—atherosclerosis	0.00434	0.00519	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Lovastatin—atherosclerosis	0.00433	0.00517	CcSEcCtD
Gallamine Triethiodide—Chest pain—Lovastatin—atherosclerosis	0.00433	0.00517	CcSEcCtD
Gallamine Triethiodide—Malaise—Simvastatin—atherosclerosis	0.00429	0.00512	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Simvastatin—atherosclerosis	0.00426	0.00508	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Ezetimibe—atherosclerosis	0.00424	0.00507	CcSEcCtD
Gallamine Triethiodide—Chest pain—Ezetimibe—atherosclerosis	0.00424	0.00507	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00422	0.00503	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Pravastatin—atherosclerosis	0.00421	0.00503	CcSEcCtD
Gallamine Triethiodide—Pain—Rosuvastatin—atherosclerosis	0.00419	0.005	CcSEcCtD
Gallamine Triethiodide—Confusional state—Lovastatin—atherosclerosis	0.00418	0.005	CcSEcCtD
Gallamine Triethiodide—Confusional state—Ezetimibe—atherosclerosis	0.0041	0.0049	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Lovastatin—atherosclerosis	0.00406	0.00485	CcSEcCtD
Gallamine Triethiodide—Chest pain—Simvastatin—atherosclerosis	0.00405	0.00483	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Simvastatin—atherosclerosis	0.00405	0.00483	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00403	0.00482	CcSEcCtD
Gallamine Triethiodide—Angioedema—Niacin—atherosclerosis	0.00399	0.00476	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00398	0.00476	CcSEcCtD
Gallamine Triethiodide—Anaemia—Pravastatin—atherosclerosis	0.00397	0.00474	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Ezetimibe—atherosclerosis	0.00395	0.00472	CcSEcCtD
Gallamine Triethiodide—Angioedema—Pravastatin—atherosclerosis	0.00393	0.00469	CcSEcCtD
Gallamine Triethiodide—Confusional state—Simvastatin—atherosclerosis	0.00391	0.00467	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Niacin—atherosclerosis	0.00391	0.00467	CcSEcCtD
Gallamine Triethiodide—Urticaria—Rosuvastatin—atherosclerosis	0.00389	0.00464	CcSEcCtD
Gallamine Triethiodide—Malaise—Pravastatin—atherosclerosis	0.00388	0.00463	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Rosuvastatin—atherosclerosis	0.00387	0.00462	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Pravastatin—atherosclerosis	0.00385	0.00459	CcSEcCtD
Gallamine Triethiodide—Cough—Niacin—atherosclerosis	0.00381	0.00455	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Simvastatin—atherosclerosis	0.0038	0.00454	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00378	0.00451	CcSEcCtD
Gallamine Triethiodide—Cough—Pravastatin—atherosclerosis	0.00375	0.00448	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Lovastatin—atherosclerosis	0.00373	0.00445	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Niacin—atherosclerosis	0.00372	0.00444	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00371	0.00443	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00369	0.00441	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Pravastatin—atherosclerosis	0.00366	0.00437	CcSEcCtD
Gallamine Triethiodide—Chest pain—Pravastatin—atherosclerosis	0.00366	0.00437	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Ezetimibe—atherosclerosis	0.00365	0.00436	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00361	0.00431	CcSEcCtD
Gallamine Triethiodide—Fatigue—Lovastatin—atherosclerosis	0.00358	0.00427	CcSEcCtD
Gallamine Triethiodide—Pain—Lovastatin—atherosclerosis	0.00355	0.00424	CcSEcCtD
Gallamine Triethiodide—Confusional state—Pravastatin—atherosclerosis	0.00354	0.00422	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00354	0.00422	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00351	0.0042	CcSEcCtD
Gallamine Triethiodide—Asthenia—Rosuvastatin—atherosclerosis	0.00351	0.00419	CcSEcCtD
Gallamine Triethiodide—Fatigue—Ezetimibe—atherosclerosis	0.00351	0.00419	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Simvastatin—atherosclerosis	0.00348	0.00416	CcSEcCtD
Gallamine Triethiodide—Pain—Ezetimibe—atherosclerosis	0.00348	0.00416	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Niacin—atherosclerosis	0.00348	0.00415	CcSEcCtD
Gallamine Triethiodide—Pruritus—Rosuvastatin—atherosclerosis	0.00346	0.00414	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Niacin—atherosclerosis	0.00346	0.00413	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Pravastatin—atherosclerosis	0.00343	0.0041	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Lovastatin—atherosclerosis	0.00342	0.00408	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Ezetimibe—atherosclerosis	0.00335	0.004	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00335	0.004	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Rosuvastatin—atherosclerosis	0.00335	0.004	CcSEcCtD
Gallamine Triethiodide—Fatigue—Simvastatin—atherosclerosis	0.00335	0.004	CcSEcCtD
Gallamine Triethiodide—Pain—Simvastatin—atherosclerosis	0.00332	0.00396	CcSEcCtD
Gallamine Triethiodide—Urticaria—Lovastatin—atherosclerosis	0.0033	0.00394	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Lovastatin—atherosclerosis	0.00328	0.00392	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Lovastatin—atherosclerosis	0.00328	0.00392	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00325	0.00388	CcSEcCtD
Gallamine Triethiodide—Urticaria—Ezetimibe—atherosclerosis	0.00323	0.00386	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Ezetimibe—atherosclerosis	0.00322	0.00384	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Ezetimibe—atherosclerosis	0.00322	0.00384	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Niacin—atherosclerosis	0.0032	0.00382	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Simvastatin—atherosclerosis	0.0032	0.00382	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.0032	0.00382	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Pravastatin—atherosclerosis	0.00315	0.00376	CcSEcCtD
Gallamine Triethiodide—Rash—Rosuvastatin—atherosclerosis	0.00309	0.00369	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Rosuvastatin—atherosclerosis	0.00308	0.00368	CcSEcCtD
Gallamine Triethiodide—Urticaria—Simvastatin—atherosclerosis	0.00308	0.00368	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Niacin—atherosclerosis	0.00308	0.00367	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Simvastatin—atherosclerosis	0.00307	0.00366	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Simvastatin—atherosclerosis	0.00307	0.00366	CcSEcCtD
Gallamine Triethiodide—Headache—Rosuvastatin—atherosclerosis	0.00307	0.00366	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Lovastatin—atherosclerosis	0.00306	0.00365	CcSEcCtD
Gallamine Triethiodide—Pain—Niacin—atherosclerosis	0.00305	0.00364	CcSEcCtD
Gallamine Triethiodide—Fatigue—Pravastatin—atherosclerosis	0.00302	0.00361	CcSEcCtD
Gallamine Triethiodide—Pain—Pravastatin—atherosclerosis	0.003	0.00358	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Ezetimibe—atherosclerosis	0.003	0.00358	CcSEcCtD
Gallamine Triethiodide—Asthenia—Lovastatin—atherosclerosis	0.00298	0.00355	CcSEcCtD
Gallamine Triethiodide—Pruritus—Lovastatin—atherosclerosis	0.00294	0.00351	CcSEcCtD
Gallamine Triethiodide—Asthenia—Ezetimibe—atherosclerosis	0.00292	0.00349	CcSEcCtD
Gallamine Triethiodide—Nausea—Rosuvastatin—atherosclerosis	0.00291	0.00347	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Pravastatin—atherosclerosis	0.00289	0.00345	CcSEcCtD
Gallamine Triethiodide—Pruritus—Ezetimibe—atherosclerosis	0.00288	0.00344	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Simvastatin—atherosclerosis	0.00286	0.00341	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Lovastatin—atherosclerosis	0.00284	0.00339	CcSEcCtD
Gallamine Triethiodide—Urticaria—Niacin—atherosclerosis	0.00283	0.00338	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Niacin—atherosclerosis	0.00282	0.00336	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Niacin—atherosclerosis	0.00282	0.00336	CcSEcCtD
Gallamine Triethiodide—Urticaria—Pravastatin—atherosclerosis	0.00279	0.00333	CcSEcCtD
Gallamine Triethiodide—Asthenia—Simvastatin—atherosclerosis	0.00278	0.00332	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Ezetimibe—atherosclerosis	0.00278	0.00332	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Pravastatin—atherosclerosis	0.00277	0.00331	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Pravastatin—atherosclerosis	0.00277	0.00331	CcSEcCtD
Gallamine Triethiodide—Pruritus—Simvastatin—atherosclerosis	0.00275	0.00328	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Simvastatin—atherosclerosis	0.00265	0.00317	CcSEcCtD
Gallamine Triethiodide—Vomiting—Lovastatin—atherosclerosis	0.00264	0.00315	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Niacin—atherosclerosis	0.00263	0.00313	CcSEcCtD
Gallamine Triethiodide—Rash—Lovastatin—atherosclerosis	0.00262	0.00312	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Lovastatin—atherosclerosis	0.00261	0.00312	CcSEcCtD
Gallamine Triethiodide—Headache—Lovastatin—atherosclerosis	0.0026	0.0031	CcSEcCtD
Gallamine Triethiodide—Vomiting—Ezetimibe—atherosclerosis	0.00259	0.00309	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Pravastatin—atherosclerosis	0.00258	0.00309	CcSEcCtD
Gallamine Triethiodide—Rash—Ezetimibe—atherosclerosis	0.00257	0.00306	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Ezetimibe—atherosclerosis	0.00256	0.00306	CcSEcCtD
Gallamine Triethiodide—Asthenia—Niacin—atherosclerosis	0.00256	0.00305	CcSEcCtD
Gallamine Triethiodide—Headache—Ezetimibe—atherosclerosis	0.00255	0.00304	CcSEcCtD
Gallamine Triethiodide—Pruritus—Niacin—atherosclerosis	0.00252	0.00301	CcSEcCtD
Gallamine Triethiodide—Asthenia—Pravastatin—atherosclerosis	0.00252	0.00301	CcSEcCtD
Gallamine Triethiodide—Pruritus—Pravastatin—atherosclerosis	0.00248	0.00296	CcSEcCtD
Gallamine Triethiodide—Vomiting—Simvastatin—atherosclerosis	0.00247	0.00295	CcSEcCtD
Gallamine Triethiodide—Nausea—Lovastatin—atherosclerosis	0.00246	0.00294	CcSEcCtD
Gallamine Triethiodide—Rash—Simvastatin—atherosclerosis	0.00245	0.00292	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Simvastatin—atherosclerosis	0.00244	0.00292	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Niacin—atherosclerosis	0.00244	0.00291	CcSEcCtD
Gallamine Triethiodide—Headache—Simvastatin—atherosclerosis	0.00243	0.0029	CcSEcCtD
Gallamine Triethiodide—Nausea—Ezetimibe—atherosclerosis	0.00242	0.00289	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Pravastatin—atherosclerosis	0.0024	0.00287	CcSEcCtD
Gallamine Triethiodide—Nausea—Simvastatin—atherosclerosis	0.0023	0.00275	CcSEcCtD
Gallamine Triethiodide—Vomiting—Niacin—atherosclerosis	0.00227	0.00271	CcSEcCtD
Gallamine Triethiodide—Rash—Niacin—atherosclerosis	0.00225	0.00268	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Niacin—atherosclerosis	0.00224	0.00268	CcSEcCtD
Gallamine Triethiodide—Headache—Niacin—atherosclerosis	0.00223	0.00267	CcSEcCtD
Gallamine Triethiodide—Vomiting—Pravastatin—atherosclerosis	0.00223	0.00266	CcSEcCtD
Gallamine Triethiodide—Rash—Pravastatin—atherosclerosis	0.00221	0.00264	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Pravastatin—atherosclerosis	0.00221	0.00264	CcSEcCtD
Gallamine Triethiodide—Headache—Pravastatin—atherosclerosis	0.0022	0.00262	CcSEcCtD
Gallamine Triethiodide—Nausea—Niacin—atherosclerosis	0.00212	0.00253	CcSEcCtD
Gallamine Triethiodide—Nausea—Pravastatin—atherosclerosis	0.00208	0.00249	CcSEcCtD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.000543	0.00334	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000527	0.00324	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PLA2G7—atherosclerosis	0.000527	0.00324	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.000515	0.00317	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000505	0.00311	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CCR2—atherosclerosis	0.000503	0.0031	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000498	0.00306	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL4—atherosclerosis	0.000493	0.00303	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCG—atherosclerosis	0.000493	0.00303	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—IL6—atherosclerosis	0.00049	0.00301	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.00049	0.00301	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000486	0.00299	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LDLRAP1—atherosclerosis	0.000481	0.00296	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00047	0.00289	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.000467	0.00287	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.000467	0.00287	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLTP—atherosclerosis	0.000452	0.00278	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PDGFB—atherosclerosis	0.000444	0.00273	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.000443	0.00272	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—UTS2—atherosclerosis	0.00044	0.0027	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—PRKCG—atherosclerosis	0.000439	0.0027	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—KNG1—atherosclerosis	0.000431	0.00265	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—HSPD1—atherosclerosis	0.000428	0.00263	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000424	0.00261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CX3CR1—atherosclerosis	0.000422	0.00259	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CASR—atherosclerosis	0.000422	0.00259	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000419	0.00257	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000416	0.00256	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000414	0.00254	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CX3CL1—atherosclerosis	0.000413	0.00254	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000404	0.00248	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—F2—atherosclerosis	0.000401	0.00246	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.0004	0.00246	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.0004	0.00246	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000397	0.00244	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CNR2—atherosclerosis	0.000392	0.00241	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCG8—atherosclerosis	0.000392	0.00241	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LTA4H—atherosclerosis	0.000392	0.00241	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00039	0.0024	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000387	0.00238	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HRH1—atherosclerosis	0.000386	0.00237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—atherosclerosis	0.000384	0.00236	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000365	0.00225	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CCL5—atherosclerosis	0.00036	0.00221	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000351	0.00216	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRH1—atherosclerosis	0.00035	0.00215	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—F7—atherosclerosis	0.000345	0.00212	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000342	0.00211	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00034	0.00209	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL3—atherosclerosis	0.000337	0.00207	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000326	0.002	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCG1—atherosclerosis	0.00031	0.0019	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—GHRL—atherosclerosis	0.000308	0.00189	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000305	0.00188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCR2—atherosclerosis	0.000305	0.00187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—EDNRA—atherosclerosis	0.000305	0.00187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—AGT—atherosclerosis	0.000301	0.00185	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.0003	0.00184	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ACE—atherosclerosis	0.000298	0.00183	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GHRL—atherosclerosis	0.000297	0.00183	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—FABP4—atherosclerosis	0.000291	0.00179	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LCAT—atherosclerosis	0.000291	0.00179	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000289	0.00177	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000286	0.00176	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA4—atherosclerosis	0.000286	0.00176	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP7A1—atherosclerosis	0.000281	0.00173	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000277	0.0017	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000272	0.00167	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PLAUR—atherosclerosis	0.000268	0.00165	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000268	0.00165	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000262	0.00161	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PLG—atherosclerosis	0.000262	0.00161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000261	0.00161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—KNG1—atherosclerosis	0.000261	0.0016	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP27A1—atherosclerosis	0.00026	0.0016	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGTR1—atherosclerosis	0.000259	0.00159	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000255	0.00157	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000254	0.00156	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL4—atherosclerosis	0.000253	0.00156	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000249	0.00153	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—UTS2—atherosclerosis	0.000249	0.00153	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLA2G2A—atherosclerosis	0.000246	0.00151	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALOX5AP—atherosclerosis	0.000246	0.00151	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA2—atherosclerosis	0.000246	0.00151	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALOX15—atherosclerosis	0.000246	0.00151	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000244	0.0015	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCG5—atherosclerosis	0.000243	0.00149	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000243	0.00149	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00024	0.00147	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CASR—atherosclerosis	0.000238	0.00147	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF2—atherosclerosis	0.000238	0.00146	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000237	0.00146	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPA—atherosclerosis	0.000235	0.00144	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—BGN—atherosclerosis	0.000227	0.0014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—UTS2—atherosclerosis	0.000226	0.00139	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000226	0.00139	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA5—atherosclerosis	0.000225	0.00138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR2—atherosclerosis	0.000222	0.00136	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000221	0.00136	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000221	0.00136	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—EDN1—atherosclerosis	0.00022	0.00135	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000219	0.00134	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL5—atherosclerosis	0.000218	0.00134	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	0.000217	0.00133	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLA2G1B—atherosclerosis	0.000217	0.00133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CX3CR1—atherosclerosis	0.000216	0.00133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CASR—atherosclerosis	0.000216	0.00133	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000214	0.00132	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CX3CL1—atherosclerosis	0.000212	0.0013	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000212	0.0013	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000212	0.0013	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALOX5—atherosclerosis	0.000209	0.00129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRH1—atherosclerosis	0.000207	0.00127	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR2—atherosclerosis	0.000201	0.00124	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000197	0.00121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000196	0.00121	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000193	0.00119	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP1—atherosclerosis	0.000191	0.00118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000189	0.00117	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—AGT—atherosclerosis	0.000189	0.00116	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NAMPT—atherosclerosis	0.000188	0.00115	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000187	0.00115	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LIPC—atherosclerosis	0.000186	0.00115	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOC3—atherosclerosis	0.000185	0.00114	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LEP—atherosclerosis	0.000185	0.00114	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LDLR—atherosclerosis	0.000184	0.00113	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGT—atherosclerosis	0.000182	0.00112	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CETP—atherosclerosis	0.00018	0.00111	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000177	0.00109	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—F2—atherosclerosis	0.000175	0.00107	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL3—atherosclerosis	0.000173	0.00106	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SCARB1—atherosclerosis	0.000172	0.00106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR2—atherosclerosis	0.000172	0.00106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000172	0.00106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—F2—atherosclerosis	0.000169	0.00104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GHRL—atherosclerosis	0.000168	0.00103	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000168	0.00103	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMGCR—atherosclerosis	0.000163	0.001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOA4—atherosclerosis	0.000162	0.000998	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—INS—atherosclerosis	0.000158	0.000972	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EDNRA—atherosclerosis	0.000156	0.000962	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR2—atherosclerosis	0.000156	0.000962	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000156	0.000959	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CCL2—atherosclerosis	0.000156	0.000956	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000153	0.00094	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF1—atherosclerosis	0.000153	0.00094	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GHRL—atherosclerosis	0.000152	0.000937	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL2—atherosclerosis	0.00015	0.000924	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL4—atherosclerosis	0.00015	0.00092	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP2—atherosclerosis	0.000148	0.00091	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—KNG1—atherosclerosis	0.000147	0.000906	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000147	0.000902	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000146	0.000901	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCA1—atherosclerosis	0.000145	0.000892	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOA2—atherosclerosis	0.00014	0.000859	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KNG1—atherosclerosis	0.000134	0.000823	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—UTS2—atherosclerosis	0.000133	0.00082	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGTR1—atherosclerosis	0.000133	0.000818	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CX3CR1—atherosclerosis	0.000128	0.000786	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASR—atherosclerosis	0.000128	0.000786	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CX3CL1—atherosclerosis	0.000125	0.000771	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMOX1—atherosclerosis	0.000124	0.000765	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—EDN1—atherosclerosis	0.000124	0.000764	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCL5—atherosclerosis	0.000123	0.000758	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CXCL8—atherosclerosis	0.000123	0.000756	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOB—atherosclerosis	0.000119	0.000733	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR2—atherosclerosis	0.000119	0.000731	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL8—atherosclerosis	0.000119	0.00073	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	0.000119	0.000729	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000117	0.00072	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTM1—atherosclerosis	0.000116	0.000713	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPL—atherosclerosis	0.000114	0.0007	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	0.000113	0.000693	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	0.000112	0.000688	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GPX1—atherosclerosis	0.000111	0.000683	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CD36—atherosclerosis	0.000108	0.000665	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	0.000106	0.000654	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VWF—atherosclerosis	0.000106	0.000651	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOC3—atherosclerosis	0.000105	0.000647	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LDLR—atherosclerosis	0.000105	0.000643	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	0.000103	0.000634	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTHFR—atherosclerosis	0.000102	0.00063	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL3—atherosclerosis	0.000102	0.000628	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARA—atherosclerosis	0.000101	0.000618	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NCF1—atherosclerosis	9.79e-05	0.000602	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AGT—atherosclerosis	9.73e-05	0.000599	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOE—atherosclerosis	9.54e-05	0.000586	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—F2—atherosclerosis	9.52e-05	0.000586	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CAV1—atherosclerosis	9.45e-05	0.000581	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA1—atherosclerosis	9.43e-05	0.00058	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGT—atherosclerosis	9.36e-05	0.000576	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	9.24e-05	0.000568	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR2—atherosclerosis	9.24e-05	0.000568	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CYBA—atherosclerosis	9.2e-05	0.000566	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	9.11e-05	0.00056	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GHRL—atherosclerosis	9.01e-05	0.000554	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PARP1—atherosclerosis	9.01e-05	0.000554	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLAT—atherosclerosis	9.01e-05	0.000554	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—F2—atherosclerosis	8.65e-05	0.000532	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CG—atherosclerosis	8.61e-05	0.000529	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARG—atherosclerosis	8.31e-05	0.000511	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	8.28e-05	0.000509	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—INS—atherosclerosis	8.15e-05	0.000501	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KNG1—atherosclerosis	7.9e-05	0.000486	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	7.86e-05	0.000483	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	7.71e-05	0.000474	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLG—atherosclerosis	7.66e-05	0.000471	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—atherosclerosis	7.47e-05	0.000459	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	7.25e-05	0.000446	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NOS3—atherosclerosis	7.14e-05	0.000439	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP3—atherosclerosis	7e-05	0.000431	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF2—atherosclerosis	6.97e-05	0.000429	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOB—atherosclerosis	6.77e-05	0.000416	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	6.71e-05	0.000413	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EDN1—atherosclerosis	6.66e-05	0.00041	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL5—atherosclerosis	6.61e-05	0.000406	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—atherosclerosis	6.53e-05	0.000402	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LPL—atherosclerosis	6.46e-05	0.000397	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	6.28e-05	0.000386	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SPP1—atherosclerosis	6.12e-05	0.000376	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	6.09e-05	0.000375	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	5.66e-05	0.000348	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGT—atherosclerosis	5.53e-05	0.00034	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOE—atherosclerosis	5.42e-05	0.000333	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEP—atherosclerosis	5.42e-05	0.000333	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CAV1—atherosclerosis	5.37e-05	0.00033	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOA1—atherosclerosis	5.36e-05	0.000329	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ESR1—atherosclerosis	5.17e-05	0.000318	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—F2—atherosclerosis	5.11e-05	0.000314	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	4.89e-05	0.000301	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	4.68e-05	0.000288	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INS—atherosclerosis	4.63e-05	0.000285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL2—atherosclerosis	4.55e-05	0.00028	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1—atherosclerosis	4.48e-05	0.000275	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	4.25e-05	0.000261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOS3—atherosclerosis	4.06e-05	0.00025	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	3.6e-05	0.000221	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	3.48e-05	0.000214	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—atherosclerosis	3.42e-05	0.000211	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—atherosclerosis	3.28e-05	0.000202	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—atherosclerosis	3.26e-05	0.0002	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	3.22e-05	0.000198	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	3.17e-05	0.000195	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	3.16e-05	0.000194	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	2.92e-05	0.00018	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT3—atherosclerosis	2.9e-05	0.000178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	2.77e-05	0.00017	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	2.68e-05	0.000165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.02e-05	0.000124	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.87e-05	0.000115	CbGpPWpGaD
